6541.TW
Price:
$40.2
Market Cap:
$10.65B
Tanvex BioPharma, Inc., originally known as Ruenvex Biotech, Inc., is a biopharmaceutical company founded in 2013 and based in George Town, Cayman Islands. The firm specializes in the investigation, creation, production, and sale of biosimilar medicines, with its operations spanning Taiwan and the United States. Its core mission involves developing biosimilars aimed at treating severe conditions like neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. The company's robust product portfolio includes TX01 and TX-05, both of which have successfully completed Phase III clinical trials. Additionally, TX-04 and TX-16 are currently undergoing Phase I clinical trials, while TX-5...[Read more]
Industry
Biotechnology
IPO Date
2015-08-13
Stock Exchange
TAI
Ticker
6541.TW
According to Tanvex BioPharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.55. This represents a change of -28.12% compared to the average of -9.11 of the last 4 quarters.
The mean historical PE Ratio of Tanvex BioPharma, Inc. over the last ten years is -9.06. The current -6.55 PE Ratio has changed 7.13% with respect to the historical average. Over the past ten years (40 quarters), 6541.TW's PE Ratio was at its highest in in the March 2020 quarter at -3.07. The PE Ratio was at its lowest in in the September 2016 quarter at -26.88.
Average
-9.06
Median
-7.43
Minimum
-23.92
Maximum
-3.93
Discovering the peaks and valleys of Tanvex BioPharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 156.91%
Maximum Annual PE Ratio = -3.93
Minimum Annual Increase = -57.74%
Minimum Annual PE Ratio = -23.92
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -8.97 | 22.47% |
| 2024 | -7.33 | 86.55% |
| 2023 | -3.93 | -47.91% |
| 2022 | -7.54 | -38.47% |
| 2021 | -12.25 | 156.91% |
| 2020 | -4.77 | -1.30% |
| 2019 | -4.83 | -30.52% |
| 2018 | -6.95 | -31.21% |
| 2017 | -10.11 | -57.74% |
| 2016 | -23.92 | -38.81% |
The current PE Ratio of Tanvex BioPharma, Inc. (6541.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.74
5-year avg
-8.00
10-year avg
-9.06
Tanvex BioPharma, Inc.’s PE Ratio is less than Ever Supreme Bio Technology Co., Ltd (31.02), greater than Foresee Pharmaceuticals Co., Ltd. (-67.52), greater than Medigen Vaccine Biologics Corp. (-54.32), less than Excelsior Medical Co., Ltd. (15.68), greater than AP Biosciences Inc (-21.41), less than YungShin Global Holding Corporation (18.61), less than PharmaEngine, Inc. (22.93), greater than Acepodia, Inc. (-10.04), greater than EirGenix Inc. (-19.15), less than ScinoPharm Taiwan, Ltd. (162.26),
| Company | PE Ratio | Market cap |
|---|---|---|
| 31.02 | $16.64B | |
| -67.52 | $12.87B | |
| -54.32 | $15.71B | |
| 15.68 | $13.62B | |
| -21.41 | $10.86B | |
| 18.61 | $14.68B | |
| 22.93 | $9.68B | |
| -10.04 | $7.59B | |
| -19.15 | $14.33B | |
| 162.26 | $16.49B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tanvex BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tanvex BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Tanvex BioPharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Tanvex BioPharma, Inc. (6541.TW)?
What is the highest PE Ratio for Tanvex BioPharma, Inc. (6541.TW)?
What is the 3-year average PE Ratio for Tanvex BioPharma, Inc. (6541.TW)?
What is the 5-year average PE Ratio for Tanvex BioPharma, Inc. (6541.TW)?
How does the current PE Ratio for Tanvex BioPharma, Inc. (6541.TW) compare to its historical average?